Medical Device Maker Angiotech Acquired by China Investors

A group of China investment companies closed their acquisition of Angiotech Pharma, a company that makes medical devices for wound closures and ophthalmology. Angiotech, which makes branded, private label and OEM products, is headquartered in Vancouver, Canada and operates globally, including in China. Investors expect to expand the company's China operations. The acquisition was led by Vivo Capital, a US-China life science investor, and ZQ Capital of Hong Kong. The purchase price was not disclosed. More details.... Share this with colleagues: // //